Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 18, Issue 13, 2011, Pages 3632-3639

  Ho, Meng Hsing ^a   Yu, Chih Yung ^a   Chung, Kuo Piao ^b   Chen, Teng Wei ^a   Chu, Heng Cheng ^a   Lin, Chih Kung ^a   Hsieh, Chung Bao ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; FEMALE; GENDER; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR NECROSIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 82955233466     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1803-3     Document Type: Article

References (47)

1. DM Parkin F Bray J Ferlay P Pisani 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 11668491 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D (Pubitemid 32911406)
2. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 10072408 10.1056/NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D (Pubitemid 29114292)
3. H Wakabayashi T Ushiyama K Ishimura, et al. 2003 Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions J Surg Oncol 82 98 103 12561065 10.1002/jso.10203 (Pubitemid 36164444)
4. WR Kim RS Brown Jr NA Terrault H El Serag 2002 Burden of liver disease in the United States: summary of a workshop Hepatology 36 227 242 12085369 10.1053/jhep.2002.34734 (Pubitemid 34700782)
5. V Mazzaferro E Regalia R Doci, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis N Engl J Med 334 693 699 8594428 10.1056/NEJM199603143341104 1:STN:280: DyaK287nsFWltw%3D%3D (Pubitemid 26079803)
6. S Jonas WO Bechstein T Steinmuller, et al. 2001 Vascular invasion an histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 1080 1086 11343235 10.1053/jhep.2001.23561 1:STN:280:DC%2BD3MzgvFOluw%3D%3D (Pubitemid 32378206)
7. FY Yao L Ferrell NM Bass, et al. 2001 Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 1394 1403 11391528 10.1053/jhep.2001.24563 1:STN:280:DC%2BD3MzhvFajtQ%3D%3D (Pubitemid 32496976)
8. E Mor RT Kaspa P Sheiner M Schwartz 1998 Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation Ann Intern Med 129 643 653 9786813 1:STN:280:DyaK1cvkt12gtw%3D%3D (Pubitemid 28480821)
9. K Ota S Teraoka T Kawai 1995 Donor difficulties in Japan and Asian countries Transpl Proc 27 83 86 1:STN:280:DyaK2M7osVymtQ%3D%3D
10. A Mazziotti GL Grazi A Cavallari 1998 Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience Hepatogastroenterology 45 1281 1287 9730389 (Pubitemid 28372114)
11. C Toso G Mentha NM Kneteman P Majno 2010 The place of downstaging for hepatocellular carcinoma J Hepatol 52 930 936 20385428 10.1016/j.jhep.2009.12. 032
12. KJ Oldhafer A Chavan NR Fruhauf, et al. 1998 Aterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 29 953 999 9875642 10.1016/S0168-8278(98)80123-2 1:STN:280:DyaK1M%2FptVyhsg%3D%3D (Pubitemid 28559065)
13. T Decaens F Roudot-Thoraval S Bresson-Hadni, et al. 2005 Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 767 775 15973710 10.1002/lt.20418 (Pubitemid 40975578)
14. PM Porrett H Peterman M Rosen, et al. 2006 Lack of benefit of pre-transplant locoregional hapatic therapy for hepatocellular cancer in the current MELD era Liver Transpl 12 665 673 16482577 10.1002/lt.20636
15. M Lesurtel B Mullhaupt BC Pestalozzi T Pfammatter PA Clavien 2006 Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2644 2650 16939518 10.1111/j.1600-6143.2006.01509.x 1:STN:280:DC%2BD28nhs1Crsw%3D%3D (Pubitemid 44571684)
16. RT Poon H Ngan CM Lo CL Liu ST Fan J Wong 2000 Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J Surg Oncol 73 109 114 10694648 10.1002/(SICI)1096- 9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J 1:STN:280: DC%2BD3c7mtVOrtA%3D%3D (Pubitemid 30123735)
17. FY Yao RK Kerlan Jr R Hirose, et al. 2008 Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 819 827 18688876 10.1002/hep.22412
18. DM Harnois J Steers JC Andrew, et al. 1999 Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma Liver Transpl Surg 5 192 199 10226109 10.1002/lt.500050307 1:STN:280:DyaK1M3ksVyitw%3D%3D (Pubitemid 29217989)
19. S Roayaie JS Frischer SH Emre, et al. 2002 Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 533 539 11923610 10.1097/00000658-200204000-00012 (Pubitemid 34258353)
20. IW Graziadei H Sandmueller P Waldenberger, et al. 2003 Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver transpl 9 557 563 12783395 10.1053/jlts.2003.50106 (Pubitemid 36701690)
21. A Bharat DB Brown JS Crippin, et al. 2006 Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival J Am Coll Surg 203 411 420 17000383 10.1016/j.jamcollsurg.2006.06.016 (Pubitemid 44416253)
22. LL Wong K Tanaka L Lau S Komura 2004 Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers Clin Tanspl 18 227 234 10.1111/j.1399-0012.2004.00164.x (Pubitemid 38744844)
23. M Ravaioli GL Grazi F Piscaglia, et al. 2008 Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2547 2557 19032223 10.1111/j.1600-6143.2008.02409.x 1:STN:280:DC%2BD1cjmsV2jsA%3D%3D
24. C Toso S Asthana DL Bigam AM Shapiro NM Kneteman 2009 Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of transplant recipients database Hepatology 49 832 838 19152426 10.1002/hep.22693
25. C Toso J Trotter A Wei, et al. 2008 Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver Transpl 14 1107 1115 18668667 10.1002/lt.21484
26. G Millonig IW Graziadei MC Freund, et al. 2007 Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl 13 272 279 17256758 10.1002/lt.21033 (Pubitemid 46351654)
27. Otto Gerd Herber Sascha Heise Michael, et al. 2006 Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 1260 1267 10.1002/lt.20837 (Pubitemid 44194595)
28. FY Yao M Kinkhabwala JM LaBerge, et al. 2005 The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma Am J Transplant 5 795 804 15760404 10.1111/j.1600-6143.2005.00750.x (Pubitemid 40461290)
29. E Regalia J Coppa R Pulvirenti, et al. 2001 Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience Transpl Proc 33 1442 1444 10.1016/S0041-1345(00)02546-X 1:STN:280:DC%2BD3M7mvV2itg%3D%3D (Pubitemid 32237918)
30. FY Yao L Xiao NM Bass R Kerlan NL Ascher JP Roberts 2007 Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2587 2596 17868066 10.1111/j.1600-6143.2007.01965.x 1:STN:280:DC%2BD2sngsVSjuw%3D%3D (Pubitemid 47561609)
31. TM Pawlik KA Delman JN Vauthey, et al. 2005 Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 1086 1092 16123959 10.1002/lt.20472 (Pubitemid 41341758)
32. BK Kim KH Han YN Park, et al. 2008 Prediction of microvascular invasion before curative resection of hepatocellular carcinoma J Surg Oncol 97 246 252 18095300 10.1002/jso.20953 (Pubitemid 351312165)
33. JH Lim D Choi CK Park WJ Lee HK Lim 2006 Encapsulated hepatocellular carcinoma: CT-pathologic correlations Eur Radiol 16 2326 2333 16547706 10.1007/s00330-006-0203-8 (Pubitemid 44349881)
34. CB Hsieh TW Chen CM Chu HC Chu CP Yu KP Chung 2010 Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence? World J Gastroenterol 16 3049 3055 20572309 10.3748/wjg.v16.i24.3049 1:CAS:528:DC%2BC3cXotlKjtbw%3D
35. K Yamamoto H Imamura Y Matsuyama, et al. 2009 Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy Ann Surg Oncol 16 2795 2804 19669841 10.1245/s10434-009-0618-y
36. CM Lo ST Fan CL Liu, et al. 2007 Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma Br J Surg 94 78 86 17016793 10.1002/bjs.5528 1:STN:280:DC%2BD2s%2Fhs1OktA%3D%3D (Pubitemid 46142736)
37. L Kulik M Abecassis 2004 Living donor liver transplantation for hepatocellular carcinoma Gastroenterology 127 S277 S282 15508095 10.1053/j.gastro.2004.09.042 (Pubitemid 39423397)
38. V Mazzaferro YS Chun RT Poon, et al. 2008 Liver transplantation for hepatocellular carcinoma Ann Surg Oncol 15 1001 1007 18236119 10.1245/s10434-007-9559-5
39. K Man KT Ng CM Lo, et al. 2007 Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways Liver Transpl 13 1669 1677 18044786 10.1002/lt.21193
40. K Man ST Fan CM Lo, et al. 2003 Graft injury in relation to graft size in right lobe live donor liver transaplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression Ann Surg. 237 256 264 12560784 (Pubitemid 38173253)
41. J Wands 2007 Hepatocellular carcinoma and sex N Engl J Med. 357 1974 1976 17989393 10.1056/NEJMcibr075652 1:CAS:528:DC%2BD2sXht1ymtbbP (Pubitemid 350074697)
42. K Dohmen H Shigematsu K Irie H Ishibashi 2003 Longer survival in female than male with hepatocellular carcinoma J Gastroenterol Hepatol 18 267 272 12603526 10.1046/j.1440-1746.2003.02936.x (Pubitemid 36513155)
43. WE Naugler T Sakurai S Kim, et al. 2007 Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 121 124 17615358 10.1126/science.1140485 1:CAS:528:DC%2BD2sXnt1SjtLc%3D (Pubitemid 47056470)
44. JH Shim KM Kim YJ Lee, et al. 2010 Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection Ann Surg Oncol 17 869 877 20033326 10.1245/s10434-009-0788-7
45. SH Kim WJ Lee HK Lim JH Lim 2007 Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography J Comput Assist Tomogr 31 198 203 17414753 10.1097/01.rct.0000236424. 20514.2e (Pubitemid 46573355)
46. IR Kamel DA Bluemke J Eng, et al. 2006 The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 505 512 16567675 10.1097/01.RVI.0000200052.02183.92 (Pubitemid 44318722)
47. R Kloeckner G Otto S Biesterfeld, et al. 2010 MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma Cardiovasc Intervent Radiol 33 532 540 19847482 10.1007/s00270-009-9728-y